RMD News: With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case - 3rd May 2023, 10:59pm

annb0t

Top 20
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But as Peter Lynch said in One Up On Wall Street, 'Long shots almost never pay off.' A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up.

If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, ...

>>> Read more: With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
 
Top Bottom